HarrisMartin's MDL Conference: Xarelto, Morcellators and Emerging Torts Speaker Profiles

Neil D. Overholtz specializes in pharmaceutical litigation, and has successfully handled thousands of defective drug and medical device cases, including fen-phen, Rezulin, Baycol, Bextra/Celebrex, Vioxx, Medtronic Defibrillators, and Guidant Defibrillators.

Recently, Mr. Overholtz has the distinction of having been appointed as national counsel on the Plaintiffs’ Steering Committees for several federal products liability MDL’s (Mullti-District litigations), including the Trasylol MDL pending in federal court in West Palm Beach, Florida, before the Honorable Judge Middlebrooks, the Viagra MDL in the District Court in Minnesota, before the Honorable Judge Magnuson, as well as the Medtronic Sprint Fidelis Lead Wire MDL before United States District Court Judge Richard Kyle. Additionally, Mr. Overholtz has served as co-lead counsel in the In Re America Online, Inc Version 5.0 Software Litigation, MDL Docket No. 1341 (S.D. Fla), helping to negotiate a cash settlement for affected AOL members in excess of $15 Million as well as significant injunctive relief.

Mr. Overholtz has also recently served as co-chair of the Defective Medtronic Pacemakers and Defibrillators MDL discovery committee, and lead the firm’s efforts in national litigation, which resulted in a settlement of over $100 Million dollars. United States District Judge James Rosenbaum appointed Mr. Overholtz, to serve 25 of the Plaintiff’s Steering Committee Fee Committee. Mr. Overholtz also served a key role on the Guidant Defibrillators and Pacemakers MDL, which resulted in a settlement of over $200 Million dollars.